When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Aptose Biosciences (APTO-10.5%) slips on modestly higher volume on the heels of preliminary data from a Phase 1a/b clinical trial evaluating CG-806 patients with a range of blood cancers. The results were presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting.
More news on: Aptose Biosciences Inc., Healthcare stocks news, Stocks on the move,